Group 1: Investment Trends - The investment in the robotics sector remains strong, with significant funding rounds reported in the past week [1] - Medical device investments are also gaining traction, showcasing a robust performance in the healthcare sector [1] - A total of 22 financing events occurred in the domestic primary market from September 22 to September 28, with a total scale of approximately 3.366 billion RMB [1] Group 2: Sector-Specific Financing - The advanced manufacturing sector completed 9 financing rounds, raising over 540 million RMB, while the robotics sector had 5 financing rounds totaling approximately 1.469 billion RMB [3] - The healthcare sector saw significant investments, including a 63 million USD financing round for Haobo Pharmaceutical [8][9] Group 3: Regional Distribution of Financing - The majority of financing events were concentrated in Jiangsu, Guangdong, and Zhejiang provinces, with Jiangsu leading with 17 cases [4] Group 4: Active Investment Institutions - Active investment institutions included Eagle Investment and PwC Capital, each completing 2 financing rounds primarily in the technology and manufacturing sectors [6] Group 5: Notable Company Financing - Suzhou Laisai Intelligent Technology completed a multi-million RMB Pre-B financing round led by Eagle Investment's Star Fund and Xieli Investment [13][14] - Xingmai Innovation secured 1 billion RMB in A+ round financing, led exclusively by Meituan Longzhu [8] - Aifei Biopharmaceutical announced nearly 300 million RMB in B3 financing, aimed at accelerating clinical research for innovative cancer drugs [12]